859 related articles for article (PubMed ID: 11884766)
1. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML
JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
Steurer W; Malaise J; Mark W; Koenigsrainer A; Margreiter R;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii54-62. PubMed ID: 15814551
[TBL] [Abstract][Full Text] [Related]
3. Rejection after simultaneous pancreas-kidney transplantation.
Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
5. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients.
Ferraresso M; Ghio L; Edefonti A; Garavaglia R; Berardinelli L
Pediatr Nephrol; 2002 Aug; 17(8):664-7. PubMed ID: 12185478
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
8. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.
Saudek F; Malaise J; Boucek P; Adamec M;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii3-10, ii62. PubMed ID: 15814547
[TBL] [Abstract][Full Text] [Related]
10. Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
Doria C; Jain AK; Scott VL; Gruttadauria S; Marino IR; Doyle HR; Fung JJ
Exp Clin Transplant; 2003 Jun; 1(1):48-55. PubMed ID: 15859907
[TBL] [Abstract][Full Text] [Related]
11. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
12. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
14. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
Boots JM; van Duijnhoven EM; Christiaans MH; Nieman FH; van Suylen RJ; van Hooff JP
Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
[TBL] [Abstract][Full Text] [Related]
15. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
16. Kidney allograft outcome in simultaneous pancreas-kidney transplantation.
Nakache R; Weinbroum A; Merhav H; Kaplan E; Kariv Y; Khoury W; Gutman M; Klausner JM
Isr Med Assoc J; 2000 Jul; 2(7):517-9. PubMed ID: 10979325
[TBL] [Abstract][Full Text] [Related]
17. Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
Peddi VR; Kamath S; Munda R; Demmy AM; Alexander JW; First MR
Clin Transplant; 1998 Oct; 12(5):401-5. PubMed ID: 9787948
[TBL] [Abstract][Full Text] [Related]
18. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus rescue therapy for children with acute renal transplant rejection.
Hymes LC; Warshaw BL
Pediatr Nephrol; 2001 Dec; 16(12):990-2. PubMed ID: 11793086
[TBL] [Abstract][Full Text] [Related]
20. Kidney-pancreas transplants: is it so difficult to start a program?
Alonso A; Fernández C; Villaverde P; García R; Aguirrezabalaga J; Gómez M; Oliver J; Valdés F
Transplant Proc; 2005 Apr; 37(3):1455-6. PubMed ID: 15866636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]